ArticleInternational journal of medical sciences2026
Risk of peripheral vestibular disorders and hearing impairment among users of glucagon-like peptide-1 receptor agonists.
Jing-Yang Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.